Dr David I Malitz, MD | |
1001 Walnut St, Evansville, IN 47713-1963 | |
(812) 421-2020 | |
(812) 422-1189 |
Full Name | Dr David I Malitz |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 37 Years |
Location | 1001 Walnut St, Evansville, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982671194 | NPI | - | NPPES |
100242920A | Medicaid | IN | |
64878085 | Medicaid | KY | |
100510131 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 10979 (Nevada) | Secondary |
207W00000X | Ophthalmology | 01041297 (Indiana) | Primary |
207W00000X | Ophthalmology | 30753 (Kentucky) | Secondary |
Entity Name | David I Malitz Md., Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568439784 PECOS PAC ID: 7416909437 Enrollment ID: O20050217000376 |
News Archive
Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs.
The Society of Interventional Radiology (SIR) announced the addition of 18 Fellows to the Fairfax, Virginia-based, national organization's roster during SIR's 38th Annual Scientific Meeting, held April 13 in New Orleans.
Temptime Corporation announced today that it will donate its Vaccine Vial Monitors (VVMs) to the World Health Organization (WHO) to monitor potential heat damage of H1N1 vaccines to be distributed by WHO to developing countries most in need.
Diet and aerobic exercise are highly effective for the treatment of type 2 diabetes, but not for obese subjects that have developed the disease when very young. A study at the Institute for Research in Biomedicine and Trinity College in Dublin demonstrates that obese subjects between 18 and 25 years of age carry mitochondrial proteins and genes that work abnormally and that these anomalies contribute to generating insulin resistance and a reduced response to physical exercise.
In this interview, News-Medical talks to Dr. Jan Westerink about recent studies into Novo Nordisk's semaglutide and its potential benefits for Type 2 Diabetes patients, that he and Novo Nordisk collaborated on.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David I Malitz, MD 1001 Walnut St, Evansville, IN 47713-1963 Ph: (812) 421-2020 | Dr David I Malitz, MD 1001 Walnut St, Evansville, IN 47713-1963 Ph: (812) 421-2020 |
News Archive
Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs.
The Society of Interventional Radiology (SIR) announced the addition of 18 Fellows to the Fairfax, Virginia-based, national organization's roster during SIR's 38th Annual Scientific Meeting, held April 13 in New Orleans.
Temptime Corporation announced today that it will donate its Vaccine Vial Monitors (VVMs) to the World Health Organization (WHO) to monitor potential heat damage of H1N1 vaccines to be distributed by WHO to developing countries most in need.
Diet and aerobic exercise are highly effective for the treatment of type 2 diabetes, but not for obese subjects that have developed the disease when very young. A study at the Institute for Research in Biomedicine and Trinity College in Dublin demonstrates that obese subjects between 18 and 25 years of age carry mitochondrial proteins and genes that work abnormally and that these anomalies contribute to generating insulin resistance and a reduced response to physical exercise.
In this interview, News-Medical talks to Dr. Jan Westerink about recent studies into Novo Nordisk's semaglutide and its potential benefits for Type 2 Diabetes patients, that he and Novo Nordisk collaborated on.
› Verified 1 days ago
Dr. William G Carey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 954 S Kenmore Dr, Evansville, IN 47714 Phone: 812-402-2020 Fax: 812-402-5300 | |
Dr. Michael R Hodges, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1020 W Buena Vista Rd, Evansville, IN 47710 Phone: 812-423-3131 Fax: 812-426-7020 | |
Dr. Sally G Primus, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1449 Kimber Ln Ste 102a, Evansville, IN 47715 Phone: 126-162-0208 Fax: 812-616-1400 | |
Dr. Terry W Talley, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 201 W Iowa St, Evansville, IN 47710 Phone: 812-424-2020 Fax: 812-424-3000 | |
Dr. Theodore Jere Stransky, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 350 W Columbia St, Suite 250, Evansville, IN 47710 Phone: 812-423-3161 | |
Dr. Thomas A Brummer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6149 E Columbia St, Evansville, IN 47715 Phone: 812-424-2020 Fax: 812-424-3000 | |
Andrew Taylor Strand, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6149 E Columbia St, Evansville, IN 47715 Phone: 812-424-2020 Fax: 812-424-3000 |